Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy Now?
Is EWTX a good stock to buy? We came across a bullish thesis on Edgewise Therapeutics, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on EWTX.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 15,518,492 | $630,516,330 | 11.68% | |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 10,215,455 | $415,053,937 | +39% | 7.77% |
| 3. | RA Capital Management Peter Kolchinsky | 8,392,730 | $340,996,620 | -20% | 2.96% |
| 4. | Driehaus Capital Richard Driehaus | 4,728,623 | $192,123,952 | +6% | 1.11% |
| 5. | Perceptive Advisors Joseph Edelman | 4,373,974 | $177,714,564 | -2% | 2.67% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.64 | 10,700 | $199,403.06 | 23,702 | 2025-11-11 | Filing | |
| $20.13 | 124,193 | $2,500,005.09 | 443,792 | 2025-04-03 | Filing | |
| $20.13 | 372,578 | $7,499,995.14 | 14,809,075 | 2025-04-03 | Filing | |
| $20.13 | 124,193 | $2,500,005.09 | 443,792 | 2025-04-03 | Filing | |
| $20.13 | 372,578 | $7,499,995.14 | 14,809,075 | 2025-04-03 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.41 | 2,919 | $126,703.57 | 8,625 | 2026-08-13 | Filing | |
| $44.52 | 800 | $35,614.00 | 11,544 | 2026-08-12 | Filing | |
| $44.43 | 104 | $4,620.23 | 12,344 | 2026-08-12 | Filing | |
| $43.71 | 2,779 | $121,462.59 | 12,448 | 2026-08-12 | Filing | |
| $43.78 | 2,839 | $124,302.78 | 15,227 | 2026-08-12 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 735,202 | $29,849,201 | 0.03% | |
| 2. | 110,815 | $4,499,100 | 1.15% | |
| 3. | 85,563 | $3,473,858 | 0.66% | |
| 4. | 11,482 | $466,169 | 0.01% | |
| 5. | 5,000 | $203,000 | 0.14% |